Tesofensine dosage calculator
Enter a vial and a dose and this returns the concentration, the volume and the syringe units. Underneath it, the same arithmetic worked out in advance for common vials, and the doses published studies of Tesofensine actually used, every one quoted and cited. It converts numbers. It does not suggest what to take.
Work out concentration and what to draw
Two divisions, both shown. Concentration = mass in the vial ÷ diluent volume. Volume to draw = mass you want ÷ that concentration. Syringe units are that volume × the units per millilitre on your syringe's own scale.
Worked example: 5 mg in 2 mL is 2,500 mcg/mL, so 250 mcg is 0.1 mL, which is 10 units on a U-100 syringe and 4 units on a U-40. The scale is printed on the barrel; reading a U-40 syringe as if it were U-100 is a two-and-a-half-fold error.
Tesofensine reconstitution chart
Units on a standard U-100 insulin syringe, where 100 units is 1 mL. The rows are the absolute doses quoted in studies of Tesofensine, from 500 mcg to 50 mg, so this chart is specific to this compound rather than a generic ladder. More diluent means more units for the same dose, which is easier to measure accurately and empties the vial no faster.
| Dose | 1 mL diluent (2,000 mcg/mL) | 2 mL diluent (1,000 mcg/mL) | 3 mL diluent (667 mcg/mL) |
|---|---|---|---|
| 500 mcg | 25 | 50 | 75 |
| 1 mg | 50 | 100 | 150 >1 mL |
| 1.2 mg | 60 | 120 >1 mL | 180 >1 mL |
| 2 mg | 100 | 200 >1 mL | 300 >1 mL |
| 50 mg | 2,500 >1 mL | 5,000 >1 mL | 7,500 >1 mL |
| Dose | 1 mL diluent (5,000 mcg/mL) | 2 mL diluent (2,500 mcg/mL) | 3 mL diluent (1,667 mcg/mL) |
|---|---|---|---|
| 500 mcg | 10 | 20 | 30 |
| 1 mg | 20 | 40 | 60 |
| 1.2 mg | 24 | 48 | 72 |
| 2 mg | 40 | 80 | 120 >1 mL |
| 50 mg | 1,000 >1 mL | 2,000 >1 mL | 3,000 >1 mL |
| Dose | 1 mL diluent (10,000 mcg/mL) | 2 mL diluent (5,000 mcg/mL) | 3 mL diluent (3,333 mcg/mL) |
|---|---|---|---|
| 500 mcg | 5 | 10 | 15 |
| 1 mg | 10 | 20 | 30 |
| 1.2 mg | 12 | 24 | 36 |
| 2 mg | 20 | 40 | 60 |
| 50 mg | 500 >1 mL | 1,000 >1 mL | 1,500 >1 mL |
Read a figure off this chart only if it matches the vial in front of you. A vial labelled a different strength, or reconstituted with a different volume, gives a different number for the same dose, and that is the single most common way these calculations go wrong.
Doses in published studies of Tesofensine
Each row is quoted from a paper in this compound's source ledger and carries the kind of evidence it came from. 6 of 6 come from human studies; the rest are animal or laboratory work.
| Evidence | Dose as the paper states it | Source |
|---|---|---|
| Human clinical trial | Obese adults took 0.25, 0.5 or 1.0 mg once daily with diet for 24 weeks, losing 4.5%, 9.2% and 10.6% of body weight against 2.0% on diet and placebo. | pmid-18950853 |
| Human clinical trial | The combination Tesomet paired 0.5 mg tesofensine with 50 mg metoprolol once daily for 24 weeks in hypothalamic obesity. | pmid-35294397 |
| Human clinical trial | Early Parkinson's patients took 0.25, 0.5 or 1.0 mg daily for 14 weeks. | pmid-17149725 |
| Human clinical trial | Advanced Parkinson's patients took 0.125, 0.25, 0.5 or 1 mg once daily for 14 weeks. | pmid-18474731 |
| Human clinical trial | Healthy volunteers received single six-hour infusions of 0.3 to 1.2 mg in a rising-dose pharmacokinetic study. | pmid-19705923 |
| Observational, human | Twenty-eight volunteers took a single 2 mg oral dose, half of them with itraconazole. | pmid-20000889 |
Weight-normalised doses, and why they are not on the chart
Some studies state a dose per kilogram. Those figures are deliberately absent from the chart above, because multiplying one by a body weight produces a number that looks like a dose and is not one. Interspecies scaling is not arithmetic: a rat milligram-per-kilogram figure does not become a human dose by multiplication.
- Animal study, rats, 2010: weight-normalized doses as published: 2.0 mg/kg; 0.5-3.0 mg/kg; 1.5 mg/kg; 0.3 mg/kg. DIO rats treated with tesofensine (2.0 mg/kg, s.c.) for 16 days showed significantly lower body weights than vehicle-treated DIO rats, being reflected by a marked hypophagic response. pmid-20200509
How long studies ran, and how far a vial goes
A vial lasts for a number of draws, not a number of weeks: divide the mass in the vial by the mass per draw and round down, which the vial planner does. How long that represents depends on frequency. For context, these are the durations studies of Tesofensine actually ran for.
- Randomized controlled trial, humans, 2009: durations stated: 24 weeks. In total 203 obese persons were randomised to treatment with Tesofensine 0.25, 0.5, or 1.0 mg, or placebo daily for 24 weeks. pmid-19824222
- Randomized controlled trial, humans, 2008: durations stated: 6 months. Weight-loss drugs produce an additional mean weight loss of only 3-5 kg above that of diet and placebo over 6 months, and more effective pharmacotherapy of obesity is needed. pmid-18950853
- Randomized controlled trial, humans, 2008: durations stated: 14 weeks. Tesofensine (0.125, 0.25, 0.5, or 1 mg) or placebo tablets were administered once daily for 14 weeks. pmid-18474731
- Randomized controlled trial, humans, 2007: durations stated: 5 years. Two hundred sixty-one subjects with PD < 5 years and not receiving dopaminergic treatment were randomly assigned to daily treatment with NS 2330 at 0.25 mg, 0.5 mg, 1.0 mg, or placebo. pmid-17149725
- Human study, humans, n=28, 2010: durations stated: 6 days; 5 days. Overall, 28 subjects received a single oral dose of tesofensine 2 mg; 14 of these subjects were coadministered an oral itraconazole 400 mg loading dose and a 200 mg maintenance dose for 6 days before and 5 days after administration of tesofensine. pmid-20000889
Storage and stability, as published
Reconstitution starts a clock. These are the storage and stability conditions stated in papers in this ledger. They describe what the study did, which is not the same as a shelf life for a vial in your fridge.
- In vitro study, humans, 2025: Tesofensine and dasotraline stabilize DAT in an outward-facing conformation, while centanafadine, ansofaxine, and nefazodone capture the inward-facing conformation. pmid-41392177
How Tesofensine was given
The route changes what a dose means. The same number given intravenously and subcutaneously is not the same exposure.
- Randomized controlled trial, humans, 2009: administration by intravenous route reported. The aim of this analysis was to accomplish a model that is able to describe typical plasma concentration-time profiles of compounds undergoing EHC using data from intravenous studies of tesofensine and meloxicam. pmid-19705923
- Randomized controlled trial, humans, n=320, 2007: administration by oral route reported. Plasma data from 320 subjects undergoing multiple oral dosing, and consisting of 1969 NS2330 and 1714 metabolite concentrations were fitted simultaneously using NONMEM. pmid-17324246
- Human study, humans, n=28, 2010: administration by oral route reported. Overall, 28 subjects received a single oral dose of tesofensine 2 mg; 14 of these subjects were coadministered an oral itraconazole 400 mg loading dose and a 200 mg maintenance dose for 6 days before and 5 days after administration of tesofensine. pmid-20000889
- Animal study, rats, 2010: administration by subcutaneous route reported. DIO rats treated with tesofensine (2.0 mg/kg, s.c.) for 16 days showed significantly lower body weights than vehicle-treated DIO rats, being reflected by a marked hypophagic response. pmid-20200509
Questions people ask
- How many units is 500 mcg of Tesofensine?
- It depends entirely on how the vial was reconstituted. In a 5 mg vial with 2 mL of diluent it is 20 units on a U-100 syringe; with 1 mL it is 10. The chart above gives the rest.
- Does adding more diluent waste the peptide?
- No. The mass in the vial does not change. More diluent spreads the same mass through more liquid, so each dose is a larger, easier-to-measure volume and the vial yields exactly as many doses as before.
- Why does this page not recommend a dose?
- Because a dose is a clinical decision rather than a division. It depends on why someone is taking something, what else they take and how their kidneys and liver are working, none of which is knowable from a number typed into a box.
- Where do the doses in the table come from?
- Each is quoted from a specific paper indexed in Europe PMC, linked in the source column, and labelled with the kind of study it came from. The full evidence is on the Tesofensine record.
What this calculator will not do
It will not take a body weight and return a milligram figure, and it will not tell you how often to draw. The table above is the published record, not a menu. A dose that appeared in a trial appeared under supervision, with monitoring, in people selected for that trial.
Other calculators
- Generic reconstitution calculatorThe same arithmetic, without a compound attached
- Unit convertermg, mcg, ng and syringe units
- Vial plannerDraws per vial and how long it lasts
- All compound calculatorsEvery compound with published dose figures